NovoCure Limited
Viés de alta

NVCR primed for an extended run

Kept the chart simple but there are a lot of bullish aspects at play here:

- ready for markup after an accumulation phase
- coming off a wave 5 correction apprx. 0.786 off the highs last June
- looking at weekly chart you’ll see a larger running flat structure
- earnings as a catalyst and overall great company!

*Initial Target by Apr 14 = 99
** Target range by 5/20/2022 = 108-116

Would love to hear your thoughts on this.
Beyond Technical Analysishealthcaremedicaldevicesnot-financial-advice

Aviso legal